Posted by Surbhi on July 17 2026 at 03:54 PM
public
The minimal residual disease (MRD) testing market — molecular diagnostic assays that detect trace, sub-clinical cancer cells or circulating tumor DNA remaining after treatment, often months befor...
The cancer gene therapy market represents one of the most dynamic and innovation-driven areas of modern oncology, centered on the use of genetic material to modify, repair, silence, or introduce ...
